PMC:7696151 / 60412-60606 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1764","span":{"begin":2,"end":5},"obj":"Chemical"}],"attributes":[{"id":"A1764","pred":"tao:has_database_id","subj":"1764","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":". HCQ treatment improved glycemic control, as demonstrated by the decrease of glycated hemoglobin by up to 1% respect to the placebo, without any side effects [107]. An open-label longitudinal s"}

{"project":"LitCovid-sentences","denotations":[{"id":"T387","span":{"begin":2,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":". HCQ treatment improved glycemic control, as demonstrated by the decrease of glycated hemoglobin by up to 1% respect to the placebo, without any side effects [107]. An open-label longitudinal s"}